Net earnings per share (EPS TTM): Azitra Corp (AZTR)

Graphic logo of azitrainc.com (AZTR)

The current rolling earnings per share level for Azitra, Inc. (AZTR) correlates with the implementation of robotic microbiome analysis, which accelerates testing. The value -13.06 shows the current value of the metric. The production cycle is based on outsourcing through US CMO plants. Stable management focuses on microbial dermatology and the optimization of clinical trial recruitment, maintaining investor confidence in the asset.

AZTR Azitra Corporation Earnings per share for the last 12 months (02/21/2024 - 11/12/2026)

Comprehensive metric breakdowns and analytics for Azitra Inc (AZTR)

- current quotes and average value forecast:
Price Chart Azitra, Inc.|AZTR - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Capitalization Azitra, Inc.|AZTR - Company Buyout Price
- business book valuation details:
Net Assets per Single Share Azitra|AZTR - Accounting Capitalization|Market Capitalization to Book Value Ratio azitrainc.com|AZTR - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Azitra, Inc.|AZTR - Long-Term Liabilities to Equity|Short-Term Debt to Capital Azitra Corp|AZTR - Company Total Debt Obligations|Debt to Book Value Azitra, Inc.|AZTR - Amount of Long-Term Liabilities|Company Short-Term Debt Azitra|Quick Ratio azitrainc.com
- earnings and multiples data:
AZTR - Net Profit|Future Profit Azitra, Inc.|AZTR - Company Value to Net Income|Forward P/E Multiple Azitra|AZTR - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Azitra, Inc.|AZTR - Operating profit before amortization|Net earnings per share (EPS TTM) Azitra|AZTR - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months azitrainc.com|AZTR - Expected net earnings per share growth this year|Earnings growth forecast for next year Azitra, Inc.
Fundamental company analysis:Azitra, Inc. - AZTR
Flagship merchandise of Azitra Inc

For the biotech startup Azitra, Inc. (AZTR), TTM net income per share serves as a marker of financial viability. This indicator measures total income distributed across the entire share issuance over the last twelve months. This calculation offsets the impact of secondary offerings, allowing for an assessment of real capitalization efficiency. In the microbiome therapy niche, steady growth of this metric confirms resilience against expansion by beauty behemoths. Negative dynamics signal risks of development devaluation upon the emergence of strong competitors.

Who Azitra, Inc. competes with

KRYS - Earnings per share for the last twelve months|APGE - Net earnings per share (EPS TTM)|ARQT: Net earnings per share (EPS TTM)|VCEL - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Oruka Corp|Earnings per share for the last 12 months SMTI (Sanara)|Net earnings per share (EPS TTM) DBVT|Net earnings per share (EPS TTM) solesence.com (SLSN)|Journey Medical Corporation - Net earnings per share for the last 12 months|FBRX (Forte Biosciences Inc.) - Earnings per one share for the last 12 months|Empro - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Sol-Gel Technologies, Ltd. SLGL|AXIL (reviveprocare.com) - Net earnings per share for the last 12 months|MDCX: Earnings per share for the last four quarters|Earnings per share for the last twelve months Verrica Pharmaceuticals Inc|HOTH: Earnings per share for the trailing year|Net earnings per share (EPS TTM) BFRI|Net earnings per share (EPS TTM) vynetherapeutics.com (VYNE)|Sonoma Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year QNRX|Dermata Therapeutics, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Elevai Labs Inc ELAB|Revance Therapeutics, Inc (RVNC) - Earnings per share for the last twelve months